###begin article-title 0
###xml 80 88 80 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 88 93 <span type="species:ncbi:10090">mouse</span>
The proprotein convertase PC5/6 is protective against intestinal tumorigenesis: in vivo mouse model
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 321 330 321 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 472 480 472 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
The secretory basic amino acid-specific proprotein convertases (PCs) have often been associated with cancer/metastasis. By controlling the cleavage of cancer-associated proteins, PCs play key roles in multiple steps of cancer development. Most analyses of the implication of PCs in cancer/metastasis relied on the use of in vitro overexpression systems or inhibitors that can affect more than one PC. Aside from the role of furin in salivary gland tumorigenesis, no other in vivo genetic model of PC-knockout was reported in relation to cancer development.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 87 95 87 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 424 427 424 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 427 430 427 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min</italic>
###xml 427 433 427 433 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Min</italic>/+ </sup>
###xml 654 657 654 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 657 660 657 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min</italic>
###xml 657 663 657 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Min</italic>/+ </sup>
###xml 942 945 942 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 945 948 945 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min</italic>
###xml 945 951 945 951 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Min</italic>/+ </sup>
###xml 141 146 <span type="species:ncbi:9606">human</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 418 423 <span type="species:ncbi:10090">mouse</span>
###xml 530 534 <span type="species:ncbi:10090">mice</span>
###xml 951 955 <span type="species:ncbi:10090">mice</span>
Since PC5/6 is highly expressed in the small intestine, the present study examined its in vivo role in intestinal tumorigenesis. Analysis of human intestinal tumors at various stages showed a systematic down-regulation of PC5/6 expression. Since gene inactivation of PC5/6 leads to lethality at birth, we generated mice lacking PC5/6 in enterocytes and analyzed the impact of the presence or absence of this PC in the mouse ApcMin/+ model that develops numerous adenocarcinomas along the intestinal tract. This resulted in viable mice with almost no expression of PC5/6 in small intestine, but with no overt phenotype. The data showed that by themselves ApcMin/+ tumors express lower levels of PC5/6 mRNA, and that the lack of PC5/6 in enterocytes results in a significantly higher tumor number in the duodenum, with a similar trend in other intestinal segments. Finally, the absence of PC5/6 is also associated with a premature mortality of ApcMin/+ mice.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 101 106 <span type="species:ncbi:10090">mouse</span>
###xml 133 138 <span type="species:ncbi:9606">human</span>
Overall, these data suggest that intestinal PC5/6 is protective towards tumorigenesis, especially in mouse duodenum, and possibly in human colon.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 80 86 80 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCSK1 </italic>
###xml 89 94 89 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCSK9</italic>
###xml 205 206 205 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 207 208 207 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 307 308 307 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 330 331 330 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 344 345 344 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 618 619 618 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 721 722 721 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 732 733 732 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 760 765 760 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 768 777 768 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">submitted</italic>
Nine secretory proprotein convertases (PCs) of the subtilisin/kexin type (genes PCSK1 to PCSK9) were identified in mammals and are known as: PC1/3, PC2, furin, PC4, PC5/6, PACE4, PC7, SKI-1/S1P and PCSK9 [1,2]. The first 7 convertases cleave secretory precursor proteins at single or paired basic residues [2], whereas SKI-1/S1P [3] and PCSK9 [4] do not require a basic residue at the cleavage site. The basic amino acid (aa)-specific convertases process precursors of growth factors, receptors, polypeptide hormones, adhesion molecules, proteases, as well as cell surface proteins of infectious viruses and bacteria [2]. In some cases, furin and/or PC5/6 inactivate proteins such as endothelial and lipoprotein lipases [5], PCSK9 [6] and N-cadherin (Maret D. et al., submitted).
###end p 9
###begin p 10
###xml 147 148 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 167 175 167 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 402 410 402 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 530 531 530 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 565 567 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 662 664 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 665 667 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
Overexpression of PC5/6, PACE4 and furin revealed that these proteinases can often cleave the same precursors, indicating a functional redundancy [6-12]. Evidence for in vivo redundancy was provided by furin inactivation in the liver, which revealed that most of the precursors analyzed were still processed, although to a lesser extent, in the absence of this ubiquitous convertase [13]. In contrast, in vivo studies demonstrated that in a spatio-temporal manner furin can uniquely process the Ac45 subunit of the vacuolar type H+-ATPase in pancreatic beta-cells [14] and PC5/6 the TGFbeta-like growth and differentiation factor Gdf11 in the developing embryo [15,16].
###end p 10
###begin p 11
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 270 271 270 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 411 412 407 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 413 415 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 416 418 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 419 421 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 422 424 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 425 427 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 465 467 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
Various precursors cleaved by overexpressed furin, PC5/6, PACE4 and PC7 have been previously implicated in cancer and associated metastatic processes [17-19]. A correlation between the mRNA levels of some of these PCs and the degree of tumorigenicity has been reported [9,18-27]. Furthermore, injection/implantation of various cell lines expressing PC inhibitors, such as the antitrypsin derivative alpha1-PDX [9,12,20,24,27,28] or the inhibitory prodomain of PCs [26] suggested a critical role of the PCs in tumor growth and/or metastasis.
###end p 11
###begin p 12
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 639 643 639 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">via </italic>
###xml 675 677 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 781 782 781 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 783 785 783 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 816 821 816 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pcsk5</italic>
###xml 837 842 837 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pcsk5</italic>
###xml 842 846 842 846 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 968 970 968 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 971 973 971 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1160 1162 1160 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1163 1165 1163 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1166 1168 1166 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1232 1237 1232 1237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pcsk5</italic>
###xml 1237 1241 1237 1241 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1250 1252 1250 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 303 307 <span type="species:ncbi:10090">mice</span>
The convertase PC5/6 (previously known as PC5 or PC6) was characterized in 1993 and shown to be composed of two differentially spliced isoforms, a short 915 aa soluble PC5/6A [29], and a long membrane-bound 1877 aa PC5/6B [30]. In adult rodents, PC5/6 exhibits a wide tissue distribution [29], which in mice when analyzed by quantitative PCR (QPCR) revealed that the adrenal cortex and small intestine are the richest sources of PC5/6A and PC5/6B, respectively [31]. However, the function of PC5/6 in these tissues has not been addressed. PC5/6 can bind cell surface heparan sulfate proteoglycans and tissue inhibitors of metalloproteases via its C-terminal Cys-rich domain [32]. It also seems to differ from the other convertases in that it can get activated at the cell surface [1,33]. Knockout of the PC5/6 gene (Pcsk5) revealed that Pcsk5-/- animals die at birth due to multiple malformations, including defects in antero-posterior patterning and heart formation [15,16]. Defective specification of segment identity, which leads to an increased number of thoracic and lumbar vertebrae and lack of tail, is likely due to the absence of processing of Gdf11 [15,16,34]. No obvious malformations were seen in the small intestine of Pcsk5-/- embryos [15].
###end p 12
###begin p 13
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 516 518 516 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 569 570 565 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 571 573 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 600 605 596 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 608 617 604 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">submitted</italic>
###xml 123 128 <span type="species:ncbi:9606">human</span>
The specific role of PC5/6 in tumorigenesis/metastasis has not yet been investigated. PC5/6 expression was not detected in human breast, and generally not induced in breast cancer since it was present in only 2/30 tumors [35]. In contrast, its mRNA levels seem to correlate with tumor aggressiveness of head and neck- and lung tumor-derived cell lines [18], suggesting that PC5/6 may play a different role in metastasis compared to tumor growth. Whether this is related to its ability to process adhesion molecules [36], including the alpha-chain of various integrins [7,37] and N-cadherin (Maret D. et al., submitted) is not yet clear.
###end p 13
###begin p 14
###xml 129 132 129 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 132 135 132 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min</italic>
###xml 132 138 132 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Min</italic>/+ </sup>
###xml 173 177 173 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min </italic>
###xml 178 207 178 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">multiple intestinal neoplasia</italic>
###xml 225 258 225 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc (adenomatous polyposis coli) </italic>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 489 492 489 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 492 495 492 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min</italic>
###xml 492 498 492 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Min</italic>/+ </sup>
###xml 541 545 541 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min </italic>
###xml 615 618 615 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 618 621 618 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min</italic>
###xml 618 624 618 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Min</italic>/+ </sup>
###xml 85 90 <span type="species:ncbi:10090">mouse</span>
###xml 270 274 <span type="species:ncbi:10090">mice</span>
###xml 456 460 <span type="species:ncbi:10090">mice</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
###xml 523 527 <span type="species:ncbi:10090">mice</span>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
Colorectal cancer is the third most common form of cancer in the Western world. As a mouse model for this pathology, we used the ApcMin/+ strain that harbors a heterozygote Min (multiple intestinal neoplasia) mutation in the Apc (adenomatous polyposis coli) gene. These mice spontaneously develop polyps all along the small intestine [38,39]. In order to assess the role of PC5/6 in intestinal tumorigenesis, we generated PC5/6 intestine-specific knockout mice (iKO) and crossed them with ApcMin/+ mice. Our data show that mice carrying the Min mutation but lacking PC5/6 tend to exhibit a higher tumor number than ApcMin/+ mice, especially in duodenum, and die significantly earlier.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
Animals
###end title 16
###begin p 17
###xml 40 42 40 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 48 51 48 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 51 54 51 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min</italic>
###xml 51 57 51 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Min</italic>/+ </sup>
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 195 201 195 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pcsk5 </italic>
###xml 219 224 219 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP </italic>
###xml 231 236 231 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pcsk5</italic>
###xml 236 240 236 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flox</italic>
###xml 241 245 241 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flox</italic>
###xml 236 245 236 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>flox</italic>/<italic>flox</italic></sup>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 369 374 369 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pcsk5</italic>
###xml 374 378 374 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flox</italic>
###xml 379 384 379 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flox </italic>
###xml 374 384 374 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>flox</italic>/<italic>flox </italic></sup>
###xml 705 710 705 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP </italic>
###xml 727 732 727 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pcsk5</italic>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
###xml 283 287 <span type="species:ncbi:10090">mice</span>
###xml 384 388 <span type="species:ncbi:10090">mice</span>
Tg(Vil-cre) mice (stock number 004586) [40] and ApcMin/+ mice (stock number 002020) [39] were from The Jackson Laboratory. Conditional knockout mice, in which the proximal promoter and exon 1 of Pcsk5 were flanked with loxP sites (Pcsk5flox/flox) [15], were crossed with Tg(Vil-cre) mice that express Cre under the control of the villin promoter. After two generations,Pcsk5flox/flox mice carrying (intestinal KO; iKO) or not (wild type; WT) one copy of the transgene were obtained and further intercrossed, yielding the F4 progeny used in this study, which exhibits a mixed background consisting of ~ 70% C57BL/6; 25% 129Sv and less than 5% SJL. When expressed, Cre leads to the recombination of the two loxP sites present in Pcsk5, resulting in the excision of ~ 3 kb of DNA including exon 1 (Delta1 alleles) and thereby gene inactivation.
###end p 17
###begin title 18
###xml 17 22 <span type="species:ncbi:10090">mouse</span>
Tumor scoring in mouse intestine
###end title 18
###begin p 19
###xml 41 43 41 43 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 15 19 <span type="species:ncbi:10090">mice</span>
Four month old mice were sacrificed by CO2 asphyxiation, and the whole intestine was immediately removed and rinsed with ice-cold PBS. The intestine was divided into duodenum, jejunum, ileum and colon. All sections were carefully split longitudinally, fixed in 8% paraformaldehyde, stained with 8% methylene blue and the tumors were counted under a binocular microscope.
###end p 19
###begin title 20
Quantitative RT-PCR
###end title 20
###begin p 21
###xml 303 308 301 306 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12-18</sub>
###xml 603 605 601 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 632 633 630 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 485 490 <span type="species:ncbi:9606">human</span>
###xml 731 736 <span type="species:ncbi:9606">human</span>
###xml 746 751 <span type="species:ncbi:10090">mouse</span>
Tissue samples were dissected from PBS-rinsed intestine. Total RNA was extracted using Trizol reagent (Invitrogen), as recommended by the manufacturer. Typically, 250 ng of total RNA were used for cDNA synthesis in a total volume of 20 muL using SuperScript II reverse transcriptase, 25 mug/mL oligo(dT)12-18, 0.5 mM 2'-deoxynucleoside 5'-triphosphates, and 40 U of RNaseOUT, all products from Life Technologies, and used according to the recommendations of the manufacturer. cDNAs of human adenocarcinomas were purchased from Origene. The quantitative PCR (QPCR) was performed as previously described [41]. Specific primers (Table 1) were used for the simultaneous amplification of the normalizing cDNA for ribosomal protein S14 (human) or S16 (mouse), and the gene of interest.
###end p 21
###begin p 22
Sequences of primers used for QPCR
###end p 22
###begin title 23
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
In situ hybridization
###end title 23
###begin p 24
###xml 102 104 102 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 114 116 114 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 306 308 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse cRNA probes corresponding to the coding region for aa 20 to 348 of PC5/6 were synthesized using 35S-UTP and 35S-CTP (>1,000 Ci/mmol; Amersham Bioscience, Piscataway, NJ). Cryosections (8-10 mum) were fixed for 1 hour in 4% formaldehyde and hybridized overnight at 55degreesC as previously described [42]. For autoradiography, the sections were dipped in photographic emulsion (NTB-2, Kodak, Rochester, NY), exposed for 6-12 days, and developed in D19 solution (Kodak).
###end p 24
###begin title 25
PCNA immunohistochemistry
###end title 25
###begin p 26
###xml 200 205 <span type="species:ncbi:10090">mouse</span>
Tissues were fixed overnight in 4% paraformaldehyde at 4degreesC and embedded in paraffin. Proliferation cell nuclear antigen (PCNA) was visualized in sections of 6 mum thickness by incubation with a mouse antibody (1:50; Vector laboratories, Burlingame, CA) and a biotin-labeled secondary antibody (PerkinElmer, Boston, MA), and revelation with the Vectastain kit (Vector laboratories). Sections were also counterstained with hematoxylin and eosin.
###end p 26
###begin title 27
Results
###end title 27
###begin title 28
Expression of PC5/6 is lower in intestinal tumors versus adjacent normal tissues
###end title 28
###begin p 29
###xml 125 127 125 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 614 617 614 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 617 620 617 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min</italic>
###xml 617 623 617 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Min</italic>/+ </sup>
###xml 729 733 729 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min </italic>
###xml 740 744 740 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc </italic>
###xml 901 903 901 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 904 906 904 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 912 917 912 917 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min/+</sup>
###xml 1203 1204 1203 1204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1327 1329 1327 1329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1349 1351 1349 1351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1383 1385 1383 1385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 1459 1466 1459 1466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus </italic>
###xml 1639 1641 1639 1641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 1759 1760 1759 1760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1804 1806 1804 1806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 346 351 <span type="species:ncbi:9606">human</span>
###xml 530 535 <span type="species:ncbi:9606">human</span>
###xml 595 600 <span type="species:ncbi:10090">mouse</span>
###xml 623 627 <span type="species:ncbi:10090">mice</span>
###xml 793 801 <span type="species:ncbi:9606">patients</span>
###xml 940 945 <span type="species:ncbi:10090">mouse</span>
###xml 1015 1020 <span type="species:ncbi:9606">human</span>
Mining cancer gene expression database  revealed that PC5/6 expression was significantly reduced in 7 out of 10 tumor types (P < 0.0001); [see Additional file 1: figure S1]. Since PC5/6 expression is highest in the adult small intestine [29,31], and as no data were available for intestinal cancers, PC5/6 mRNA levels were analyzed by QPCR in 22 human colon tumors at stages I, II, III or IV and compared to those of their match-paired normal adjacent tissue (Figure 1A). PC5/6 expression was on average ~ 7.6-fold lower in these human tumors. To assess whether PC5/6 was similarly regulated in mouse, we used the ApcMin/+ mice, which spontaneously develop numerous tumors in the small intestine due to the heterozygote mutation Min in the Apc gene. This mutation was originally discovered in patients suffering from familial adenomatous polyposis and frequently found in sporadic colorectal cancers [38,39]. ApcMin/+-induced tumors in the mouse small intestine constitute a good model for colonic tumorigenesis in human. We first quantified the expression levels of furin, PC5/6, PACE4 and PC7, which transit through the constitutive secretory pathway and cleave their substrates after basic residues [2]. While PACE4 and PC7 did not show any significant change, furin and PC5/6 mRNA levels were on average ~ 1.5-fold higher (P = 0.003) and lower (P = 0.0008), respectively (Figure 1B). Closer analysis of the duodenum-, jejunum- and ileum-associated tumors versus their adjacent normal tissues revealed a 1.9-, 1.2- and 1.4-fold higher furin levels, respectively, and a 2-, 1.7- and 1.1-fold lower PC5/6 expression, respectively (Figure 1C). Using specific primers, we showed that this lower level primarily affected PC5/6B transcripts [see Additional file 22: figure S2], which dominate in intestine [31]. The above data thus indicated that PC5/6 is down-regulated in many tumor types, including intestinal ones, and that in the latter furin undergoes an opposite up-regulation. Both PC5/6 and furin exhibited the greatest changes in the duodenum. These data prompted us to verify if intestinal tumorigenesis was favored in absence of PC5/6.
###end p 29
###begin p 30
###xml 51 58 51 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus </italic>
###xml 0 81 0 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Decreased expression of PC5/6 in intestinal tumors <italic>versus </italic>adjacent normal tissues</bold>
###xml 362 365 362 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 365 368 365 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min</italic>
###xml 365 371 365 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Min</italic>/+ </sup>
###xml 824 826 824 826 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 892 894 892 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 906 908 906 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 922 924 922 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 930 934 930 934 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-11 </sup>
###xml 945 947 945 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 104 109 <span type="species:ncbi:9606">human</span>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
Decreased expression of PC5/6 in intestinal tumors versus adjacent normal tissues. (A) RNA samples from human colonic adenocarcinomas (stage I, II, III or IV) and their adjacent normal tissues were submitted to QPCR analysis (n = 6, 7, 7 and 2 for stages I, II, III and IV, respectively). (B) In each small intestine section (duodenum, jejunum and ileum) from 3 ApcMin/+ mice, 2 tumors and their adjacent normal tissue (6 couples/section) were dissected and assessed for the expression levels of furin, PC5/6, PACE4 and PC7 by QPCR. Normalized expression values are shown for the 18 samples of normal tissues and 18 samples of tumors. (C) Expression of PC5/6 and furin in tumors was also analyzed by intestinal section. All mRNA levels in tumors were normalized to their respective normal tissue expression and have been log2 transformed, with the median of the total 18 samples set to 0. *, P < 0.05; **, P < 0.005; ***, P < 5.10-11 (Student's t test).
###end p 30
###begin title 31
###xml 28 34 28 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pcsk5 </italic>
Conditional inactivation of Pcsk5 in enterocytes
###end title 31
###begin p 32
###xml 15 23 15 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 128 132 128 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 145 150 145 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pcsk5</italic>
###xml 150 154 150 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flox</italic>
###xml 155 160 155 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flox </italic>
###xml 150 160 150 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>flox</italic>/<italic>flox </italic></sup>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 318 323 318 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pcsk5</italic>
###xml 323 327 323 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flox</italic>
###xml 328 333 328 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flox </italic>
###xml 323 333 323 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>flox</italic>/<italic>flox </italic></sup>
###xml 381 384 381 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/0</sup>
###xml 401 404 401 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink">0/0</sup>
###xml 508 514 508 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pcsk5 </italic>
###xml 575 583 575 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 932 934 932 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 1059 1061 1059 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1269 1277 1269 1277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 1408 1409 1408 1409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1465 1467 1465 1467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1473 1481 1473 1481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 1924 1925 1924 1925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 190 194 <span type="species:ncbi:10090">mice</span>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
###xml 602 606 <span type="species:ncbi:10090">mice</span>
###xml 782 786 <span type="species:ncbi:10090">mice</span>
###xml 943 947 <span type="species:ncbi:10090">mice</span>
To explore the in vivo role of PC5/6 in intestinal tumor formation, we specifically inactivated its gene in enterocytes using a loxP/Cre system. Pcsk5flox/flox mice were bred to Tg(Vil-cre) mice that expressed the Cre recombinase under the direction of the villin promoter, specifically expressed in enterocytes [40]. Pcsk5flox/flox mice carrying one copy of the transgene (iKO; Tg+/0) or none (WT; Tg0/0) were generated. To verify that the presence of the transgene resulted in an efficient inactivation of Pcsk5 in enterocytes, we analyzed PC5/6 mRNA levels using QPCR and in situ hybridization in 3 mice of each genotype. Duodenum, jejunum, ileum and colon sections were dissected for further RNA extraction and tissue sectioning. Cre expression under the villin promoter in iKO mice was highest in duodenum and progressively diminished along the intestinal tract to reach ~ 25% of the duodenum level in the distal colon (Figure 2A). In WT mice, PC5/6 expression is elevated in the small intestine, especially in the duodenum, as compared to colon (Figure 2B). Indicative of the Cre efficiency all along the intestine, the absolute numbers of PC5/6 mRNA remaining in all sections of iKO intestine were very similar: 1.6 to 3.1 PC5/6 mRNA/1000 S16 mRNA. Furthermore, in situ hybridization with a PC5/6 cRNA probe confirmed that PC5/6 transcripts were strongly reduced in iKO intestinal enterocytes (Figure 3). The low residual expression observed by QPCR (Figure 2B) and in situ hybridization labeling suggest that in the small intestine PC5/6 is mainly expressed in enterocytes, but to a much less extent expressed in other cell types all along the intestine. Finally, the morphology and proliferation of enterocytes was assessed by immunohistochemistry. No gross malformation was observed and labeling with PCNA, a marker for proliferation, was not significantly different between the two genotypes [see Additional file 3: figure S3].
###end p 32
###begin p 33
###xml 26 32 26 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pcsk5 </italic>
###xml 0 43 0 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Efficient inactivation of <italic>Pcsk5 </italic>in iKO mice</bold>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
Efficient inactivation of Pcsk5 in iKO mice. (A) Cre expression was assessed in intestinal segments from 3 iKO mice. Expression values were normalized to that of S16 mRNA. (B) PC5/6 expression was quantified in each intestinal segment from 3 WT and 3 iKO mice and normalized to that of S16. Error bars represent SEM.
###end p 33
###begin p 34
###xml 58 66 58 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 0 79 0 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Detection of PC5/6 transcripts in WT and iKO intestine by <italic>in situ </italic>hybridization</bold>
###xml 223 225 223 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
Detection of PC5/6 transcripts in WT and iKO intestine by in situ hybridization. Cryosections were hybridized with a PC5/6-specific probe, stained with cresyl violet and dipped in an autoradiography emulsion. The extent of 35S labeling was visualized on dark field.
###end p 34
###begin title 35
PC5/6 deficiency has a significant impact on Min mutation-induced tumorigenesis in the duodenum
###end title 35
###begin p 36
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pcsk5</italic>
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flox</italic>
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flox </italic>
###xml 23 33 23 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>flox</italic>/<italic>flox </italic></sup>
###xml 44 47 44 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/0</sup>
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pcsk5</italic>
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flox</italic>
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flox </italic>
###xml 60 70 60 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>flox</italic>/<italic>flox </italic></sup>
###xml 70 73 70 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 73 76 73 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min</italic>
###xml 73 78 73 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Min</italic>/+</sup>
###xml 119 123 119 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min </italic>
###xml 135 138 135 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min</sup>
###xml 231 235 231 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min </italic>
###xml 270 273 270 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min</sup>
###xml 356 360 356 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min </sup>
###xml 375 379 375 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min </sup>
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 645 649 645 649 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min </sup>
###xml 694 698 694 698 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min </sup>
###xml 704 706 704 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 721 723 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 819 820 819 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 975 979 975 979 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min </sup>
###xml 988 995 988 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus </italic>
###xml 1047 1049 1047 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 1108 1110 1108 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 211 215 <span type="species:ncbi:10090">mice</span>
###xml 360 364 <span type="species:ncbi:10090">mice</span>
###xml 379 383 <span type="species:ncbi:10090">mice</span>
###xml 649 653 <span type="species:ncbi:10090">mice</span>
###xml 698 702 <span type="species:ncbi:10090">mice</span>
###xml 733 737 <span type="species:ncbi:10090">mice</span>
###xml 979 983 <span type="species:ncbi:10090">mice</span>
###xml 1004 1008 <span type="species:ncbi:10090">mice</span>
Intercrossing of [Pcsk5flox/flox Tg(Vil-cre)+/0] with [Pcsk5flox/flox ApcMin/+] generates 25% mice that carry only the Min mutation (WTMin), and exhibit normal levels of PC5/6 in intestine. Another 25% of these mice carry both the Min mutation and the Cre transgene (iKOMin), and lack PC5/6 expression in enterocytes. Duodenum, jejunum and ileum from 11 WTMin mice and 17 iKOMin mice were dissected out, opened longitudinally and stained with methylene blue (Figure 4A). All the tumors, including those exceeding 2 mm in diameter, were counted along the entire section of each tissue. The average tumor density (tumors/cm) in the duodenum of iKOMin mice was significantly higher than that in WTMin mice (P = 0.01; Figure 4B). In iKO mice, the duodenum is the tissue in which the PC5/6 drop was the most drastic (Figure 2). However, although this trend was observed in other intestinal sections, it did not reach statistical significance, and the total number of tumors in iKOMin mice, 58 versus 46 in WT mice, was not significantly higher (Figure 4C). In addition, the numbers of large tumors (>2 mm; Figure 4C) were very similar in both cases. Overall, this analysis indicates that only in duodenum does the loss of PC5/6 significantly enhance intestinal tumorigenesis.
###end p 36
###begin p 37
###xml 32 36 32 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min </sup>
###xml 43 47 43 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min </sup>
###xml 0 51 0 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Intestinal tumor formation in WT<sup>Min </sup>and iKO<sup>Min </sup>mice</bold>
###xml 86 90 86 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min </sup>
###xml 97 101 97 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min </sup>
###xml 233 237 233 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min </sup>
###xml 244 248 244 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min </sup>
###xml 275 279 275 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min </sup>
###xml 295 299 295 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min </sup>
###xml 412 414 412 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 432 434 432 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 299 303 <span type="species:ncbi:10090">mice</span>
###xml 393 397 <span type="species:ncbi:10090">mice</span>
Intestinal tumor formation in WTMin and iKOMin mice. (A) Representative sections of WTMin and iKOMin ileum stained with methylene blue. Arrows point at visualized tumors. (B) Total tumor numbers and large tumor (> 2 mm) numbers in WTMin and iKOMin intestine of 4 month-old WTMin (n = 11) and iKOMin mice (n = 17). (C) Numbers of tumors per cm of duodenum, jejunum, ileum or colon in the above mice are shown. *, P < 0.05 (Student's t test)
###end p 37
###begin title 38
###xml 43 46 43 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 46 49 46 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min</italic>
###xml 46 52 46 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Min</italic>/+ </sup>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
PC5/6 deficiency shortens the half-life of ApcMin/+ mice
###end title 38
###begin p 39
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc </italic>
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min</italic>
###xml 4 10 4 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Min</italic>/+ </sup>
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 156 160 156 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min </sup>
###xml 247 251 247 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">see </italic>
###xml 251 258 251 258 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Methods</bold>
###xml 362 364 362 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 379 380 379 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 447 450 447 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 450 453 450 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min</italic>
###xml 450 456 450 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Min</italic>/+ </sup>
###xml 552 554 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 577 581 577 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min </sup>
###xml 678 682 678 682 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min </sup>
###xml 738 740 738 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 863 865 863 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 441 445 <span type="species:ncbi:10090">mice</span>
###xml 456 460 <span type="species:ncbi:10090">mice</span>
###xml 581 585 <span type="species:ncbi:10090">mice</span>
###xml 682 686 <span type="species:ncbi:10090">mice</span>
###xml 857 861 <span type="species:ncbi:10090">mice</span>
###xml 1001 1009 <span type="species:ncbi:9606">patients</span>
Apc Min/+ mice having a pure C57BL/6 background were reported to die by 120 days of age [38,39], likely due to severe chronic anemia [38]. In this study, WTMin mice exhibited a longer half-life of 180 days, possibly due to their mixed background (see Methods). However, in the absence of intestinal PC5/6, this half-life was significantly shortened to 140 days (P = 0.03; Figure 5), suggesting that PC5/6 exerts a protective effect on these mice. ApcMin/+ mice develop anemia with a severity that seems to depend on the density of intestinal adenomas [38]. Considering that iKOMin mice had a trend for higher numbers of tumors, especially in the duodenum, premature death of iKOMin mice could be the result of more severe chronic anemia [38], which could be exacerbated by multiple hemorrhages, as observed in the liver and subcutaneously in PC5/6 knockout mice [15]. In the future, it may be valuable to examine whether PC5/6 levels correlate with the survival rate, or intestinal bleeding/anemia of patients that suffer from colorectal carcinomas.
###end p 39
###begin p 40
###xml 22 25 22 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 25 28 25 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min</italic>
###xml 25 31 25 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Min</italic>/+ </sup>
###xml 0 59 0 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Decreased survival of <italic>Apc</italic><sup><italic>Min</italic>/+ </sup>mice in the absence of PC5/6</bold>
###xml 81 85 81 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min </sup>
###xml 101 105 101 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Min </sup>
###xml 134 136 134 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
Decreased survival of ApcMin/+ mice in the absence of PC5/6. Survival rates of WTMin (n = 21) and iKOMin (n = 22) mice were compared. P = 0.03 (Log-rank test)
###end p 40
###begin title 41
Discussion
###end title 41
###begin p 42
###xml 145 146 141 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 147 149 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 150 152 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 153 155 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 215 217 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 338 340 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 605 607 601 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 620 622 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 623 625 619 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 841 849 837 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 972 974 968 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1057 1063 1053 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PLAG1 </italic>
###xml 1201 1203 1197 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 134 143 <span type="species:ncbi:10090">nude mice</span>
###xml 209 213 <span type="species:ncbi:10116">rats</span>
###xml 426 430 <span type="species:ncbi:10090">mice</span>
###xml 578 582 <span type="species:ncbi:10090">mice</span>
###xml 711 716 <span type="species:ncbi:10090">mouse</span>
###xml 913 917 <span type="species:ncbi:10090">mice</span>
###xml 986 990 <span type="species:ncbi:10090">mice</span>
The use of general PC-inhibitors such as alpha1-PDX or pro-furin revealed that PC-inhibition decrease tumorigenesis and metastasis in nude mice [9,12,20,26], but enhance metastasis in immunosuppressed newborn rats [43]. This is probably due to the ability of overexpressed PC-inhibitors to block the activity of more than one convertase [44], which may exert opposite regulating effects and modulate multiple processes. Thus, mice lacking a specific convertase should represent a more powerful tool to assess the specific function of a single convertase. Of all the PC knockout mice, those lacking furin [45] and PC5/6 [15,16] exhibit a fully penetrant embryonic lethal phenotype, precluding their use in adult mouse studies. Tissue-specific knockouts thus provide a potential approach to test their effect in cancer/metastasis. So far, the in vivo role of a specific PC in tumorigenesis was only investigated in mice lacking furin in salivary glands among other tissues [46]. In these mice, the simultaneous inactivation of furin and overexpression of the PLAG1 transcription factor, which induced the formation of adenomas in salivary glands, showed that the absence of furin delayed tumorigenesis [46], suggesting a pro-tumorigenic effect of furin.
###end p 42
###begin p 43
###xml 165 172 165 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 184 187 184 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 187 190 187 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min</italic>
###xml 187 193 187 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Min</italic>/+ </sup>
###xml 283 290 283 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus </italic>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 355 358 355 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 358 361 358 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min</italic>
###xml 358 364 358 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Min</italic>/+ </sup>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 567 570 567 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 570 573 570 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min</italic>
###xml 570 576 570 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Min</italic>/+ </sup>
###xml 610 611 610 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 744 746 744 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 791 793 791 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 952 954 952 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 955 957 955 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 958 960 958 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
###xml 331 339 <span type="species:ncbi:9606">patients</span>
###xml 364 368 <span type="species:ncbi:10090">mice</span>
###xml 576 580 <span type="species:ncbi:10090">mice</span>
###xml 687 691 <span type="species:ncbi:10090">mice</span>
The present study is the first attempt to assess the role of PC5/6 in cancer development using knockout mice. The impact of PC5/6 has been analyzed here exclusively in vivo, using the ApcMin/+ intestinal tumorigenesis model. We first evaluated PC5/6 mRNA levels in intestinal tumors versus normal tissue obtained from colon cancer patients (Figure 1A) or ApcMin/+ mice (Figure 1B and 1C), and showed that PC5/6 is systematically down-regulated in intestinal tumors. To probe the role of PC5/6 in tumorigenesis, we compared the number and size of intestinal tumors in ApcMin/+ mice lacking or not PC5/6 (Figure 4). The data showed a trend for an enhanced tumorigenesis in PC5/6-deficient mice, reaching significance only in the duodenum (Figure 4B) where PC5/6 is primarily expressed (Figure 2A), suggesting that it may exert specific functions therein. This result was unexpected in view of the reported reduced tumorigenesis by general PC-inhibitors [18,20-22].
###end p 43
###begin p 44
###xml 366 371 366 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 374 383 374 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">submitted</italic>
###xml 558 559 558 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 822 824 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 874 876 874 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1115 1117 1115 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1140 1142 1140 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1158 1160 1155 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 1208 1212 1205 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">via </italic>
###xml 1275 1280 1272 1277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 1283 1292 1280 1289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">submitted</italic>
Could PC5/6 specifically process a tumor-suppressor or inactivate a tumorigenic factor, and hence act in an opposite fashion to other basic aa-specific PCs? Opposing functions can occur by cleavage of the same substrate at different sites, as illustrated by the ability of furin to activate the cell adhesion molecule N-cadherin and PC5/6 to inactivate it (Maret D. et al., submitted). In the duodenum, PC5/6 was only 1.7-fold less abundant than furin, while its ratio to furin was 3- to 10-fold lower in other segments of the intestine [see Additional file 44: figure S4]. Thus, tumorigenesis in the duodenum may depend on the balance between activation and/or inactivation of proteins by resident furin and PC5/6, respectively. In tumors of the duodenum, PC5/6 mRNA levels are ~ 7-fold lower than those of furin (Figure 1C). Thus, the pro-tumorigenic properties of furin [46] may in some cases overshadow the protective effect of PC5/6. We surmise that within the duodenum, furin may activate precursors implicated in epithelial to mesenchymal transition, involved in early tumorigenesis and invasion/metastasis [47], such as E-cadherin [48] and TGF-beta [49], while PC5/6 may inhibit tumorigenesis, e.g., via inactivation of adhesion proteins such as N-cadherin (Maret D. et al., submitted), resulting in a lower number of tumors.
###end p 44
###begin title 45
Conclusion
###end title 45
###begin p 46
###xml 109 112 109 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 112 115 112 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min</italic>
###xml 112 117 112 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Min</italic>/+</sup>
###xml 252 255 252 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 255 258 255 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min</italic>
###xml 255 261 255 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Min</italic>/+ </sup>
###xml 288 289 288 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 591 593 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 648 656 648 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 836 837 836 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 838 840 838 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 841 843 841 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
Future studies aimed to identify the implicated substrates will require an extensive comparative analysis of ApcMin/+-induced tumors isolated from mice lacking PC5/6, furin or both in enterocytes. Whether the mechanism behind the shortened survival of ApcMin/+ mice lacking PC5/6 (Figure 5) is due to more severe hemorrhages resulting from a greater vessel fragility induced by the loss of PC5/6 [15] would require a more detailed examination. Furthermore, the importance of specific PCs in the invasion/metastasis process, which is heavily regulated by adhesion molecules processed by PCs [17,27] is yet to be fully investigated in an appropriate in vivo model. Finally, this is the first report that emphasizes the opposite roles of furin and PC5/6 in tumorigenesis. Thus, recently proposed treatments aimed to reduce furin activity [9,18-27] should include careful monitoring of their effects on PC5/6 levels and/or activity.
###end p 46
###begin title 47
Abbreviations
###end title 47
###begin p 48
###xml 57 60 49 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apc</italic>
###xml 122 128 114 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pcsk5 </italic>
###xml 134 137 126 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Min</italic>
###xml 239 244 231 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pcsk5</italic>
aa: amino acid; alpha1-PDX: alpha1-antitrypsin Portland; Apc: adenomatous polyposis coli; iKO: intestinal knockout of the Pcsk5 gene; Min: multiple intestinal neoplasia; PC: Proprotein convertase; PCNA: proliferation cell nuclear antigen; Pcsk5: Proprotein convertase subtilisin/kexin type 5; QPCR: quantitative RT-PCR; Tg: transgene; WT: wild type.
###end p 48
###begin title 49
Competing interests
###end title 49
###begin p 50
This work was supported by Canadian Institutes of Health Research grant # 44363, a Canada Chair # 201652, and a Strauss foundation grant. The authors declare that they have no competing interests.
###end p 50
###begin title 51
Authors' contributions
###end title 51
###begin p 52
All authors read and approved the final manuscript.
###end p 52
###begin p 53
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
XS carried out all the mouse analyses, tumor measurements and other experiments as well as the genotyping. RE generated the PC5/6 conditional knockout mice and helped in the analyses of their phenotypes, NGS participated in the design of the experiments, analysis of the data and writing of the manuscript, and AP was the major driver of the project implicated in all aspects of the research.
###end p 53
###begin title 54
Supplementary Material
###end title 54
###begin title 55
Additional file 1
###end title 55
###begin p 56
###xml 0 54 0 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Down-regulation of PC5/6 expression in various cancers</bold>
###xml 181 183 181 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 233 235 233 235 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
Down-regulation of PC5/6 expression in various cancers. Datasets were retrieved from ONCOMINE (a cancer microarray database and integrated data-mining platform) with a threshold of P < 0.0001. PC5/6 expression value in tumors was log2 transformed and normalized by that in the adjacent normal tissue.
###end p 56
###begin p 57
Click here for file
###end p 57
###begin title 58
Additional file 2
###end title 58
###begin p 59
###xml 69 76 69 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus </italic>
###xml 0 99 0 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Decreased expression of PC5/6B, but not PC5/6A, in intestinal tumors <italic>versus </italic>adjacent normal tissues</bold>
###xml 342 344 342 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 373 375 373 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
Decreased expression of PC5/6B, but not PC5/6A, in intestinal tumors versus adjacent normal tissues. Specific primers were used for QPCR analysis of the two PC5/6 isoforms. Normal (N) and tumoral (T) expression of PC5A and PC5B was assessed by using isoform-specific primers. Error bars represent SEM and n = 6 for each intestine section. *, P < 0.05 for PC5/6B (Student's t test)
###end p 59
###begin p 60
Click here for file
###end p 60
###begin title 61
Additional file 3
###end title 61
###begin p 62
###xml 0 47 0 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Unaffected enterocyte proliferation in iKO mice</bold>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
Unaffected enterocyte proliferation in iKO mice. Representative PCNA immunohistochemistry of WT and iKO jejunum sections is shown. Quantitative analysis was achieved by counting PCNA-positive nuclei in 3 random fields in duodenum, jejunun and ileum in 3 mice per genotype. Error bars represent SEM.
###end p 62
###begin p 63
Click here for file
###end p 63
###begin title 64
Additional file 4
###end title 64
###begin p 65
###xml 0 54 0 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Relative expression of PC5/6 and furin in WT intestine</bold>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
Relative expression of PC5/6 and furin in WT intestine. The PC5/6 and furin expression was assessed on each intestinal segment from 3 WT mice. The expression value was normalized to that of S16 mRNA. Error bars represent SEM.
###end p 65
###begin p 66
Click here for file
###end p 66
###begin title 67
Acknowledgements
###end title 67
###begin p 68
###xml 67 75 67 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
We thank Edwige and Martin Marcinkiewicz for their help for in the in situ hybridization analysis and Claudia Toulouse for the excellent animal care. We also acknowledge the editorial assistance of Brigitte Mary.
###end p 68
###begin article-title 69
The activation and physiological functions of the proprotein convertases
###end article-title 69
###begin article-title 70
Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides
###end article-title 70
###begin article-title 71
###xml 37 46 37 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 58 69 <span type="species:ncbi:11620">lassa virus</span>
The Proprotein Convertase SKI-1/S1P: in vitro analysis of lassa virus glycoprotein-derived substrates and ex vivo validation of irreversible peptide inhibitors
###end article-title 71
###begin article-title 72
The proprotein convertases are potential targets in the treatment of dyslipidemia
###end article-title 72
###begin article-title 73
Proprotein convertases are responsible for proteolysis and inactivation of endothelial lipase
###end article-title 73
###begin article-title 74
The proprotein convertase PCSK9 is inactivated by furin and/or PC5/6A: Functional consequences of natural mutations and post-translational modifications
###end article-title 74
###begin article-title 75
Endoproteolytic processing of integrin pro-alpha subunits involves the redundant function of furin and proprotein convertase (PC) 5A, but not paired basic amino acid converting enzyme (PACE) 4, PC5B or PC7
###end article-title 75
###begin article-title 76
Post-translational processing of beta-secretase (beta-amyloid- converting enzyme) and its ectodomain shedding. The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production
###end article-title 76
###begin article-title 77
###xml 85 90 <span type="species:ncbi:9606">human</span>
Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells
###end article-title 77
###begin article-title 78
Structure-Function Analysis of the Prosegment of the Proprotein Convertase PC5A
###end article-title 78
###begin article-title 79
###xml 82 105 <span type="species:ncbi:11176">Newcastle disease virus</span>
###xml 116 121 <span type="species:ncbi:9031">chick</span>
Comparison of substrate specificities against the fusion glycoprotein of virulent Newcastle disease virus between a chick embryo fibroblast processing protease and mammalian subtilisin-like proteases
###end article-title 79
###begin article-title 80
###xml 99 104 <span type="species:ncbi:9606">human</span>
Inhibition of proprotein convertases is associated with loss of growth and tumorigenicity of HT-29 human colon carcinoma cells: importance of insulin-like growth factor-1 (IGF-1) receptor processing in IGF-1- mediated functions
###end article-title 80
###begin article-title 81
###xml 57 62 <span type="species:ncbi:10090">mouse</span>
Limited redundancy of the proprotein convertase furin in mouse liver
###end article-title 81
###begin article-title 82
Role of furin in granular acidification in the endocrine pancreas: identification of the V-ATPase subunit Ac45 as a candidate substrate
###end article-title 82
###begin article-title 83
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
In vivo functions of the proprotein convertase PC5/6 during mouse development: Gdf11 is a likely substrate
###end article-title 83
###begin article-title 84
###xml 67 71 <span type="species:ncbi:10090">mice</span>
VACTERL/caudal regression/Currarino syndrome-like malformations in mice with mutation in the proprotein convertase Pcsk5
###end article-title 84
###begin article-title 85
Proprotein convertases in tumor progression and malignancy: novel targets in cancer therapy
###end article-title 85
###begin article-title 86
Proprotein convertases: "master switches" in the regulation of tumor growth and progression
###end article-title 86
###begin article-title 87
A small-molecule furin inhibitor inhibits cancer cell motility and invasiveness
###end article-title 87
###begin article-title 88
###xml 83 88 <span type="species:ncbi:9606">human</span>
Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells
###end article-title 88
###begin article-title 89
The proprotein convertases furin and PACE4 play a significant role in tumor progression
###end article-title 89
###begin article-title 90
Endo/exo-proteolysis in neoplastic progression and metastasis
###end article-title 90
###begin article-title 91
Elevated expression of proprotein convertases alters breast cancer cell growth in response to estrogen and tamoxifen
###end article-title 91
###begin article-title 92
The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis
###end article-title 92
###begin article-title 93
Inhibition of Furin-mediated Processing Results in Suppression of Astrocytoma Cell Growth and Invasiveness
###end article-title 93
###begin article-title 94
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human carcinoma cell growth and invasiveness is impaired by the propeptide of the ubiquitous proprotein convertase furin
###end article-title 94
###begin article-title 95
Opposing function of the proprotein convertases furin and PACE4 on breast cancer cells' malignant phenotypes: role of tissue inhibitors of metalloproteinase-1
###end article-title 95
###begin article-title 96
The proteolytic processing of pro-platelet-derived growth factor-A at RRKR(86) by members of the proprotein convertase family is functionally correlated to platelet-derived growth factor-A-induced functions and tumorigenicity
###end article-title 96
###begin article-title 97
###xml 22 27 <span type="species:ncbi:10090">mouse</span>
###xml 32 35 <span type="species:ncbi:10116">rat</span>
cDNA structure of the mouse and rat subtilisin/kexin-like PC5: a candidate proprotein convertase expressed in endocrine and nonendocrine cells
###end article-title 97
###begin article-title 98
Identification of an isoform with an extremely large Cys-rich region of PC6, a Kex2-like processing endoprotease
###end article-title 98
###begin article-title 99
###xml 96 101 <span type="species:ncbi:10090">mouse</span>
Deletion of the gene encoding proprotein convertase 5/6 causes early embryonic lethality in the mouse
###end article-title 99
###begin article-title 100
The Cysteine-rich Domain of the Secreted Proprotein Convertases PC5A and PACE4 Functions as a Cell Surface Anchor and Interacts with Tissue Inhibitors of Metalloproteinases
###end article-title 100
###begin article-title 101
The regulated cell surface zymogen activation of the proprotein convertase PC5A directs the processing of its secretory substrates
###end article-title 101
###begin article-title 102
Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11
###end article-title 102
###begin article-title 103
###xml 42 47 <span type="species:ncbi:9606">human</span>
Pro-protein convertase gene expression in human breast cancer
###end article-title 103
###begin article-title 104
The proprotein convertase PC5A and a metalloprotease are involved in the proteolytic processing of the neural adhesion molecule L1
###end article-title 104
###begin article-title 105
Processing of alpha4 integrin by the proprotein convertases: histidine at position P6 regulates cleavage
###end article-title 105
###begin article-title 106
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse
###end article-title 106
###begin article-title 107
###xml 58 64 <span type="species:ncbi:10090">murine</span>
Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene
###end article-title 107
###begin article-title 108
Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine
###end article-title 108
###begin article-title 109
Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia
###end article-title 109
###begin article-title 110
Nerve growth factor and proprotein convertases furin and PC7 in transected sciatic nerves and in nerve segments cultured in conditioned media: their presence in Schwann cells, macrophages, and smooth muscle cells
###end article-title 110
###begin article-title 111
###xml 91 96 <span type="species:ncbi:9606">human</span>
###xml 124 127 <span type="species:ncbi:10116">rat</span>
Inhibition of proprotein convertases enhances cell migration and metastases development of human colon carcinoma cells in a rat model
###end article-title 111
###begin article-title 112
Alpha1-antitrypsin Portland inhibits processing of precursors mediated by proprotein convertases primarily within the constitutive secretory pathway
###end article-title 112
###begin article-title 113
Failure of ventral closure and axial rotation in embryos lacking the proprotein convertase Furin
###end article-title 113
###begin article-title 114
###xml 0 4 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
MMTV-cre-mediated fur inactivation concomitant with PLAG1 proto-oncogene activation delays salivary gland tumorigenesis in mice
###end article-title 114
###begin article-title 115
Intestinal adenomagenesis involves core molecular signatures of the epithelial-mesenchymal transition
###end article-title 115
###begin article-title 116
Novel insights into cadherin processing by subtilisin-like convertases
###end article-title 116
###begin article-title 117
Evidence that furin is an authentic transforming growth factor-beta1- converting enzyme
###end article-title 117

